نتایج جستجو برای: polysaccharide vaccine

تعداد نتایج: 127703  

Journal: :Pediatrics 2006
Niels van Heerbeek Masja Straetemans Selma P Wiertsema Koen J A O Ingels Ger T Rijkers Anne G M Schilder Elisabeth A M Sanders Gerhard A Zielhuis

BACKGROUND Otitis media with effusion (OME) is very common during childhood. Because Streptococcus pneumoniae is one of the most common bacterial pathogens involved in OME, pneumococcal vaccines may have a role in the prevention of recurrent OME. OBJECTIVE We sought to assess the effect of combined pneumococcal conjugate and polysaccharide vaccinations on the recurrence of OME. METHODS A ra...

Journal: :Vaccine 2006
Hila Amir-Kroll Luis Riveron Maria E Sarmiento Gustavo Sierra Armando Acosta Irun R Cohen

Neisseria meningitidis type B is a major world-health problem. The Meningococcus type B capsular polysaccharide (MnB) is very poorly immunogenic and no vaccine to the antigen exists. Here, we conjugated the MnB to a T-cell carrier peptide (p458) derived from the self-60kDa heat shock protein molecule. The conjugate vaccine was effective in inducing long-lasting IgG antibodies to the MnB antigen...

2016
Young Keun Kim David LaFon Moon H Nahm

The pneumococcal conjugate vaccine (PCV) was developed to overcome the limitations of the pneumococcal polysaccharide vaccine, which produces poor immunogenicity in infants younger than 2 years. As many countries have included PCVs in national immunization programs for children, the incidence of invasive pneumococcal disease caused by vaccine type Streptococcus pneumoniae has declined markedly,...

Journal: :Journal of the Pediatric Infectious Diseases Society 2014
Eugene D Shapiro

Before a vaccine is approved for general use, its protective efficacy must be demonstrated, usually in a double-blind, randomized clinical trial, the gold standard for scientific validity [1]. Randomization assures lack of bias in allocation of the exposure (vaccine), whereas blinding assures lack of bias in ascertainment of the outcome (infection). Nevertheless, there are a number of disadvant...

2015
Md. Abu Sayeed Meagan Kelly Bufano Peng Xu Grace Eckhoff Richelle C. Charles Mohammad Murshid Alam Tania Sultana Md. Rasheduzzaman Rashu Amanda Berger Geoffrey Gonzalez-Escobedo Anjali Mandlik Taufiqur Rahman Bhuiyan Daniel T. Leung Regina C. LaRocque Jason B. Harris Stephen B. Calderwood Firdausi Qadri W. F. Vann Pavol Kováč Edward T. Ryan Pamela L. C. Small

BACKGROUND Vibrio cholerae is the cause of cholera, a severe watery diarrhea. Protection against cholera is serogroup specific. Serogroup specificity is defined by the O-specific polysaccharide (OSP) component of lipopolysaccharide (LPS). METHODOLOGY Here we describe a conjugate vaccine for cholera prepared via squaric acid chemistry from the OSP of V. cholerae O1 Inaba strain PIC018 and a re...

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2009
Claudia R C Lopes Eitan N Berezin Ting Hui Ching Jaildo de Souza Canuto Vanilda Oliveira da Costa Erika Monteiro Klering

Pneumococcal (Pnc) carriage is associated with pneumococcal diseases. Breast feeding and maternal vaccination may be a useful approach to prevent pneumococcal infection in young infants. We examined the risk of Pnc carriage by infants at six months of age after pneumococcal polysaccharide vaccination of pregnant women. We selected 139 pregnant woman. The woman were randomly allocated to receive...

2015
David J Leggat Anita S Iyer Jennifer A Ohtola Sneha Kommoori Joan M Duggan Claudiu A Georgescu Sadik A Khuder Noor M Khaskhely MA Julie Westerink

BACKGROUND Newly diagnosed HIV-positive individuals are 35 to 100-fold more susceptible to Streptococcus pneumoniae infection compared to non-infected individuals. Therefore, the 23-valent pneumococcal polysaccharide vaccine (PPV23) has previously been recommended, though efficacy and effectiveness of vaccination remains controversial. Early severe B cell dysfunction is a central feature of HIV...

Journal: :Annals of family medicine 2004
Tammy A Santibanez Richard Kent Zimmerman Mary Patricia Nowalk Ilene Katz Jewell Inis J Bardella

BACKGROUND Barriers to adult immunizations persist as current rates for pneumococcal polysaccharide vaccine (PPV) receipt among eligible adults remain below national goals. This study investigated potential barriers to patients receiving the PPV, including predisposing, enabling, environmental and reinforcing factors among physicians from a variety of practice and geographic settings. METHODS...

2015
Patrícia Coelho de Soárez Ana Marli Christovam Sartori Angela Carvalho Freitas Álvaro Mitsunori Nishikawa Hillegonda Maria Dutilh Novaes Paulo Lee Ho

OBJECTIVE To evaluate the cost-effectiveness of introducing universal vaccination of adults aged 60 years with the 23-valent pneumococcal polysaccharide vaccine (PPV23) into the National Immunization Program (NIP) in Brazil. METHODS Economic evaluation using a Markov model to compare two strategies: (1) universal vaccination of adults aged 60 years with one dose of PPV23 and 2) current practi...

Journal: :Pediatrics 2015
Julia G Harris Kristyn I Maletta Bixiang Ren Judyann C Olson

BACKGROUND AND OBJECTIVE Many pediatric rheumatology patients are at increased risk of pneumococcal disease secondary to a deficient immune system and/or immunosuppressive medications. The goal of this study was to improve pneumococcal vaccination rates in this high-risk population. METHODS Eligible patients included children at least 2 years old and adults with systemic lupus erythematosus a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید